Tag: tejvir_s_khurana

Penn Medicine Combines CRISPR and Lipid Nanoparticles to Target Duchenne Muscular Dystrophy

29 Oct 2026 2:23 a.m.

Penn Medicine researchers say a system pairing CRISPR gene editing with lipid nanoparticle delivery could halt or even reverse Duchenne muscular dystrophy progression, according to work led by Tejvir S. Khurana.

Health Science & Technology Education Medical Science Social Issues Legal Duchenne muscular dystrophy CRISPR gene editing lipid nanoparticles Penn Medicine Tejvir S. Khurana University of Pennsylvania gene therapy